Skip to main content
. 2008 Apr 28;9(2):69–82. doi: 10.1120/jacmp.v9i2.2794

Table 6.

Values of D95 for the planning target volume and differences in D95 values relative to control for each of the 10 study patients, using varying combinations of regions of interest to drive the deformations in the four‐dimensional (4D) dose calculations

Patient D95 values (cGy) D95 differences (cGy)
LHCE LHC LH LE LC L
LHCLHCE
LHCLHCE
LHLHCE
LHLHCE
LELHCE
LCLHCE
LLHCE
1 5500 5500 5500 5550 5550 5550 0 0 50 50 50
2 4750 4850 4450 4550 4500 2950 100
300
200
250
1800
3 4650 4600 4050 4350 3450 900
50
600
300
1200
3750
4 7100 7050 6950 6950 6600 6550
50
150
150
500
550
5 5100 4850 3750 2600 1450 500
250
1350
2500
3650
4600
6 3900 3400 2950 2400 1450 1100
500
950
1500
2450
2800
7 5950 5850 5650 5800 5500 4650
100
300
150
450
1300
8 5650 5450 5200 5000 4750 3350
200
450
650
900
2300
9 4500 4500 4500 4350 4050 4150 0 0
150
450
350
10 4550 4150 2650 2800 2200 500
400
1900
1750
2350
4050
RMS deviation 232 843 1104 1668 2648
Maximum deviation 500 1900 2500 3650 4600

D95=maximumdosereceivedbyatleast5%ofplanningtargetvolume;LHCE=4D dose calculation driven by deformations of lung, heart, cord, external contour; LHCE=4D dose calculation driven by deformations of lung, heart, cord;LH=4D dose calculation driven by deformations of lung, heart;LE=4D dose calculation driven by deformations of lung, external contour; LC=4D dose calculation driven by deformations of lung, cord; L=4D dose calculation driven by deformations of lung; RMS = root mean square.